A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age

Condition:   InfluenzaIntervention:   Biological: Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).Sponsor:   GlaxoSmithKlineNot yet recruiting - verified March 2016

Source: ClinicalTrials.gov - March 21, 2016 Category: Research Source Type: clinical trials